體育用品股全面隨大市造好 李寧及安踏急漲10%-11%
恆在科指及工商分類指數急升5.2%及4%推動,最高見22,372,現報22,349,續漲630點或2.9%,總成交額865億元。
體育用品股今早跟隨大市造好,尤其是藍籌安踏(02020.HK)及李寧(02331.HK)高見98.5元及74.8元,分別創近三個月及四個月高,現報98.45元及74.4元,續彈11%及9.9%。
特步(01368.HK)高見14.5元,創逾四個月高,現報14.45元,續升7.1%。361度(01361.HK)、滔博(06110.HK)及中國動向(03818.HK)升逾2%-4%,後者報0.485元,升4.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.